A Challenge: Controlling the Quality of Cell and Gene Therapies by Christoph Meyer, Alexander Sandoval, Allyson Decker, Sophia Nguyen, Susan Barr, Andreas Wirth

Subjects: “…Cell and gene therapies…”
Get full text

Mitigating Deficiencies in Evidence during Regulatory Assessments of Advanced Therapies: A Comparative Study with Other Biologicals by Magdi Elsallab, Christopher A. Bravery, Andreas Kurtz, Mohamed Abou-El-Enein

Subjects: “…cell and gene therapies…”
Get full text

Market Access Challenges and Solutions in Cell and Gene Therapy in The Netherlands by Rimma Velikanova, Sharon Wolters, Hinko S. Hofstra, Maarten J. Postma, Cornelis Boersma

Subjects: “…cell and gene therapies…”
Get full text

Case report: Stem cell-based suicide gene therapy mediated by the herpes simplex virus thymidine kinase gene reduces tumor progression in multifocal glioblastoma by Saeed Oraee-Yazdani, Mohammadhosein Akhlaghpasand, Fatemeh Rostami, Maryam Golmohammadi, Roozbeh Tavanaei, Gelareh Shokri, Maryam Hafizi, Maryam Oraee-Yazdani, Ali-Reza Zali, Masoud Soleimani

Subjects: Get full text

Data for modelling US projections of product approvals, patients treated, and product revenues for durable cell and gene therapies by Colin M. Young, Mark Trusheim, Casey Quinn

Subjects: Get full text

Integrating Artificial Intelligence for Academic Advanced Therapy Medicinal Products: Challenges and Opportunities by Cristobal Aguilar-Gallardo, Ana Bonora-Centelles

Subjects: Get full text

Forecasting the potential impact of cell and gene therapies in France: projecting product launches and patients treated by Ming Kei Lee, Sama Seyedmousavi, Sylvain Auvity, Sylvain Auvity, Bertrand Pourroy, Vincent Elleboode, Isabelle Kachaner, Christel Jansen, Herve Lilliu

Subjects: “…cell and gene therapies…”
Get full text

Editorial: Umbilical cord blood and tissue in novel therapies and haematopoiesis research by Diana Hernandez, Diana Hernandez, Robert David Danby, Robert David Danby, Robert David Danby, Sergio Querol

Subjects: Get full text

Erratum: Editorial: Umbilical cord blood and tissue in novel therapies and haematopoiesis research by Frontiers Production Office

Subjects: Get full text

An Introduction to Analytics for Autologous Cell and Gene Therapies by Christoph Meyer, Erik Rutjens, Thomas Merlin

Subjects: “…Autologous cell and gene therapy…”
Get full text

Clinical holds for cell and gene therapy trials: Risks, impact, and lessons learned by Carolyn A. Wills, Daniela Drago, Robert G. Pietrusko

Subjects: Get full text

Lentiviral Vector Bioprocessing by Christopher Perry, Andrea C. M. E. Rayat

Subjects: Get full text

Cell and gene therapy regulatory, pricing, and reimbursement framework: With a focus on South Korea and the EU by SungKyung Lee, Jong Hyuk Lee

Subjects: “…cell and gene therapy…”
Get full text

Kymriah® (tisagenlecleucel) – An overview of the clinical development journey of the first approved CAR-T therapy by Rakesh Awasthi, Harald J. Maier, Jie Zhang, Stephen Lim

Subjects: “…cell and gene therapy…”
Get full text

Newer treatment modalities in epidermolysis bullosa by Leena Bruckner-Tuderman

Subjects: “…Cell- and gene therapy…”
Get full text

Application of lipid-based nanoparticles in cancer immunotherapy by Zhongkun Zhang, Siyu Yao, Yingwen Hu, Xiaobin Zhao, Robert J. Lee

Subjects: Get full text

Efficient and safe correction of hemophilia A by lentiviral vector-transduced BOECs in an implantable device by Cristina Olgasi, Chiara Borsotti, Simone Merlin, Thorsten Bergmann, Patrick Bittorf, Adeolu Badi Adewoye, Nicholas Wragg, Kelcey Patterson, Andrea Calabria, Fabrizio Benedicenti, Alessia Cucci, Alessandra Borchiellini, Berardino Pollio, Eugenio Montini, Delfina M. Mazzuca, Martin Zierau, Alexandra Stolzing, Philip.M. Toleikis, Joris Braspenning, Antonia Follenzi

Subjects: Get full text

Hologene 5: A Phase II/III Clinical Trial of Combined Cell and Gene Therapy of Junctional Epidermolysis Bullosa by Laura De Rosa, Elena Enzo, Giulia Zardi, Christine Bodemer, Cristina Magnoni, Holm Schneider, Michele De Luca, Michele De Luca

Subjects: Get full text

MART-1 TCR gene-modified peripheral blood T cells for the treatment of metastatic melanoma: a phase I/IIa clinical trial by M.W. Rohaan, R. Gomez-Eerland, J.H. van den Berg, M.H. Geukes Foppen, M. van Zon, B. Raud, I. Jedema, S. Scheij, R. de Boer, N.A.M. Bakker, D. van den Broek, L.M. Pronk, L.G. Grijpink-Ongering, A. Sari, R. Kessels, M. van den Haak, H.A. Mallo, M. Karger, B.A. van de Wiel, C.L. Zuur, C.W. Duinkerken, F. Lalezari, J.V. van Thienen, S. Wilgenhof, C.U. Blank, J.H. Beijnen, B. Nuijen, T.N. Schumacher, J.B.A.G. Haanen

Subjects: Get full text

Elaborating the potential of Artificial Intelligence in automated CAR-T cell manufacturing by Niklas Bäckel, Simon Hort, Tamás Kis, David F. Nettleton, Joseph R. Egan, John J. L. Jacobs, Dennis Grunert, Robert H. Schmitt, Robert H. Schmitt

Subjects: Get full text